THE FAST VIEW

  • Personalised therapies offer better outcomes for patients and a potential revolution in health care.
  • We expect immunotherapy and gene therapy to facilitate these therapies.
  • Artificial intelligence and new drug development techniques create the potential for both incumbents and new entrants to take market share.
  • The COVID-19 pandemic has spurred many of these trends: expediting vaccine research; encouraging remote monitoring of trials; and increasing the use of telemedicine.
  • Health care remains highly competitive, with many existing therapeutic areas becoming more crowded.
  • We believe innovative companies that have a diverse product mix and participate in new areas of development are better placed to succeed.
  • These trends emphasise the importance of taking a global approach to identifying winners and losers.

CLICK HERE TO DOWNLOAD THE FULL ARTICLE.

Share This
0
    0
    Your Cart
    Your cart is emptyReturn to Shop